Lorus Therapeutics (now Aptose)From Speechboy to Bellboy....
Was Brucey´s only public company experience before joining EUO as Gadi Gonen´s (very well paid) BellBoy and the only thing he did there was to give speeches as IR ( they called it "Public Affairs" back then in the old days.... )
https://www.4-traders.com/business-leaders/W-Rowlands-063GV1-E/biography/
Mr. Rowlands was previously employed as Senior Vice President-Planning & Public Affairs by Aptose Biosciences, Inc. Lorus Therapeutics Presents at Bio-Europe International Partnering Conference
Source | Press Release |
Company | Aptose Biosciences |
Tags | Presentations & Events |
Date | November 18, 2003 |
Lorus also presents to German companies through Canadian sponsored event
Toronto, Canada -- November 18, 2003 -- Lorus Therapeutics Inc. (“Lorus ”) announced today that Lorus will present a review of its oncology pipeline at 2:15 p.m. on Tuesday, November 18, 2003 at Bio-Europe 2003 in Frankfurt, Germany.
Bruce Rowlands, senior advisor, will give a presentation that will highlight the company’s clinical programs, and outline the significant progress Lorus has made during the past year. Currently, Lorus has one Phase I clinical trial in the US, four Phase II clinical trials in the US and Canada, and a pivotal Phase III registration clinical trial in pancreatic cancer in North America and Europe.
Lorus will also be participating in the Canadian government sponsored partnering meeting, which presents Canadian biotechnology companies to German pharmaceutical companies to facilitate international partnership opportunities. Seventeen Canadian companies will be participating, including Lorus .
The annual Bio-Europe Conference provides a forum where international representatives in the biotechnology, pharmaceutical, and financial sector can meet to initiate and develop partnerships. The success of Bio-Europe is based on three major components: partnering, presentations, and expert workshops and panels.